Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

Enhanced safety surveillance (ESS) was conducted in the United Kingdom and Finland for Vaxigrip and Intanza 15 µg to comply with the European Medicines Agency interim guidance aimed to detect any potential increase in reactogenicity in near real time following the annual update of the influenza vacc...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Euro Surveill
Main Authors: Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Format: Artigo
Jezik:Inglês
Izdano: European Centre for Disease Prevention and Control (ECDC) 2017
Teme:
Surveillance and Outbreak Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://ncbi.nlm.nih.gov/pubmed/28494843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki